Campisi and colleagues show that the MTOR inhibitor rapamycin blocks the senescence-associated secretory phenotype (SASP) by inhibiting translation of IL1A, which prevents senescent fibroblasts from promoting tumour growth.
- Remi-Martin Laberge
- Yu Sun
- Judith Campisi
